The potential diversion of government funds for biomedical research has sparked intense debate in recent weeks. Understandably, many in the medical and scientific communities are concerned about what these changes might mean for the future of groundbreaking discoveries, treatments and cures.

Yet, for those of us in the private sector who have long recognized our role in funding innovative research, this is not a new conversation. Government funding has always been subject to shifting priorities, political cycles and budgetary constraints.

This doesn’t mean the government doesn’t have a role to play; it does, but it is ultimately the private sector that can and must step up and lead the charge in the continued advancement of biomedical research.

As someone who has lived with retinitis pigmentosa, a degenerative eye disease that left me blind decades ago, I understand the importance of biomedical research on a deeply personal level. I know firsthand what it means to live with a condition for which there is no cure, and I know how vital it is that we invest in ground-breaking scientific studies and innovations, which can lead to breakthroughs and transform lives.

After years spent in business, building and innovating in companies at the top of the luxury casino and hotel industry, my true passion lies in funding medical........

© The Hill